Please provide your email address to receive an email when new articles are posted on . They said it would never happen. We would never see it in our lifetimes. It was a dream held by millions, but ...
Viatris VTRS announced that the FDA has approved the abbreviated new drug application filed by Mylan Pharmaceuticals, a subsidiary of Viatris, which sought approval for a generic version of Restasis ...
PITTSBURGH, Feb. 3, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received approval from the U.S. Food and Drug Administration ...
Restasis (cyclosporine) is prescribed for chronic dry eye. This drug has no known drug interactions. But when used with certain eye agents, studies found it’s not effective at improving dry eye ...
Yes, people with Medicare Part D who use Restasis may be eligible for a patient assistance program called myAbbVie Assist. This article discusses whether Medicare covers Restasis, Medicare ...
Please provide your email address to receive an email when new articles are posted on . At SkyVision, we have found that generic cyclosporine A 0.05% in a lipid emulsion is not a prescription that can ...
MENLO PARK, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results